Thyra Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About Thyra Pharmaceutical
Thyra Pharmaceutical Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2017 (Seven years and two months 22 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Lakshmi Singhal, Seema Garg, Ravindra Yadav, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2017PTC326210
-
Company No.
326210
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Nov 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Thyra Pharmaceutical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmi Singhal
|
Director | 20-Nov-2017 | Current |
|
Seema Garg
|
Director | 20-Nov-2017 | Current |
|
Ravindra Yadav
|
Director | 18-Jul-2020 | Current |
|
Sunel Kumar
|
Director | 20-Feb-2020 | Current |
Financial Performance of Thyra Pharmaceutical.
Thyra Pharmaceutical Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thyra Pharmaceutical?
In 2018, Thyra Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Seemsan Overseas Private LimitedLakshmi Singhal and Seema Garg are mutual person
-
Singhal Realtors Private LimitedLakshmi Singhal is a mutual person
-
Techwolves Private Limited
Ravindra Yadav is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Thyra Pharmaceutical?
Unlock and access historical data on people associated with Thyra Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thyra Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thyra Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
